Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.
Leuk Lymphoma
; 63(8): 1980-1984, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1815818
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Leuk Lymphoma
Journal subject:
Hematology
/
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
10428194.2022.2057487
Similar
MEDLINE
...
LILACS
LIS